Michael Cooreman

Michael Cooreman

Company: Inventiva Pharma

Job title: Chief Medical Officer


Panel Discussion: Reflecting on the Last 3 Years in NASH: Is there a Horizon Beyond the Setbacks? 12:00 pm

What has worked and what hasn’t? Do we need a new normal in trial design and clinical development for NASH? Adapting mindsets: how do we ‘fail earlier’ to accelerate the pathway to successful therapies?Read more

day: Day 1 Stream 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.